Prioritization of diversity, equity, and inclusion in all facets of our work is long overdue for the clinical pharmacology community. Increasing diversity in clinical research will deepen our understanding of nuanced patient populations and help improve all patient outcomes. Fostering an inclusive and diverse workforce will lead to broader perspectives that can better inform critical decisions and create work environments where everyone can thrive. In this call to action, we invite you to join us.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024964 | PMC |
| http://dx.doi.org/10.1002/cpt.2852 | DOI Listing |
Publication Analysis
Top Keywords
diversity clinical
8
clinical pharmacology
8
call action
8
pharmacology call
4
action prioritization
4
prioritization diversity
4
diversity equity
4
equity inclusion
4
inclusion facets
4
facets work
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!